A B S T R A C T A radioimmunoassay has been developed for the measurement of 3,5-diiodo-L-tyrosine (DIT) 
INTRODUCTION
Thyroid hormone synthesis involves the iodination of tyrosine residues within the thyroglobulin molecule to form monoiodotyrosine (MIT) 1 and diiodotyrosine (DIT) followed by the coupling of two iodotyrosines to form either triiodothyronine (Ts) or thyroxine (T4) . Thyroid hormone secretion involves the proteolysis of thyroglobulin to release free iodoaminoacids within the thyroid. The free iodothyronines, T3 and T4, are secreted into the circulation, but the free iodotyrosines, MIT and DIT, are deiodinated within the thyroid epithelial cell by a specific iodotyrosine dehalogenase thereby making their iodine available for reentry into the pathway of thyroid hormone synthesis (1) . This thyroidal deiodination of iodotyrosines is thought to be so complete that no iodotyrosines are released from the thyroid and, therefore, none are present in the circulation (1) . The total organically bound iodine in plasma is, however, greater than the concentration of hormonal iodine (2) , and the total thyroidal iodine release is greater than the iodine content of thyroid hormones secreted (3) . This raises the possibility that the iodotyrosines could be released from the thyroid.
Numerous efforts have been made to measure iodotyrosines in serum or plasma, and the literature dealing with this subject has been reviewed by Rhodes (4) . Some investigators have failed to find measurable levels of iodotyrosines in the circulation while others, reporting the presence of measurable levels, disagree widely in their estimates of iodotyrosine concentration (4) (5) (6) (7) . As a result, there is confusion regarding the presence or absence of iodotyrosines in the circulation and their role in extrathyroidal iodine metabolism. Existing methods for the measurement of iodotyrosines in serum or plasma are tedious, relatively insensitive, and subject to analytical errors (4, 5) , and these methodological problems may account for the present disagreement. The recent development of radioimmunoassays for the measurement of Ts (8) (9) (10) (11) (12) and To (13, 14) has shown that these methods, with their great sensitivity and specificity, can be applied to the measurement of iodoaminoacids. The development of radioimmunoassays of the iodotyrosines might lead to new information regarding the question of their presence in the circulation and the nature of the nonhormonal iodine released from the thyroid. This is a report of the development of a radioimmunoassay of DIT. After a 24-h incubation at 4VC a previously determined amount (100 Ml) of goat anti-rabbit gamma globulin (Antibodies Inc., Davis, Calif.) was added, and the mixture was incubated for a second 24 h at 4VC. Following centrifugation for 30 min at 2000 g at 4VC the bound radioactivity was determined by measuring the radioactivity in the precipitate after aspiration of the supernate. At a final dilution of 1: 1,000 four of the five animals receiving PTg-DIT bound between 35-60% of the labelled DIT. The serum from one. rabbit was pooled and used for further studies.
METHODS
Polyethylene glycol radioimmunoassay. 100 standard curve was obtained. The effect incubation mixture was studied over 1 3.5-8.5. The optimum pH was 6.8. DIT-free serum. Pooled normal hi treated in batches with Rexyn 202 (Fish pany, Fair Lawn, N. J.) using 1 lb of serum. The treatment was repeated un remained as judged by the removal of DIT. This treatment markedly reduced th pH with smaller reductions in Na+, K total protein concentration and serum phoretic pattern were unchanged, and tl was 'only slightly reduced. The total T4 approximately 50%. Before use, the e were corrected by reconstitution to brit into the normal range. Smaller amou rabbit gamma globulin serum were si: give iodotyrosine-free second antiserum.
Comparison of polyethylene glycol an assays. When anti-rabbit gamma glob precipitate immunoglobulins in place of col, the standard curve obtained was k in Fig. 2 . This difference was due to thi in the second antiserum and was absent when DIT-free second antiserum was used. Because the percent radioactivity bound was greater in the polyethylene glycol system the first antiserum could be further diluted giving ins GIynIl 40%o bound in the "zero" tubes at final dilutions of 1: 1,750.
With this further dilution of first antibody, assay sensitivity improved (Fig. 3) . Specificity. The specificity of the DIT antiserum was examined in cross-reactivity studies. The results are expressed as the relative potency, on a weight basis, of each substance compared to DIT in displacing 50% of bound radioactive DIT. Initial studies performed in the double antibody system gave falsely high cross-reactivity estimates since the DIT content of the second antiserum was not considered in the calculations (Fig. 3) . True cross-reactivity estimates from the polyethylene glycol assay are 10 10 shown in Table I . All other substances tested had < 0.01% cross-reactivity. These included porcine thyroglobulin; teturves in the double raiodothyroformic acid; 3,5,3'-triiodothyroformic acid; 3,5, first antibody dilu-3'-triiodothyroacetic acid; 3,5,3'-triiodotlhyroproprionic acid; D-T,; 3,5-diiodothyroproprionic acid; 3,5-diiodothyroacetic acid; 3-iodothyronine; thyronine; L-tyrosine; L-tyramine; L-phyenylalanine,; L-dopamine; L-epinephrine; L-nOrepineof the pH of the phrine; bilirubin; EDTA; and sodium iodide.
the range of pH
The multiple ligand-binding system. Thyroxine-binding globulin (TBG) avidly hinds iodothyronines but not iodouman. serum was tyrosines (2, 7) . TBG added to the incubation mixture er Scientfict Corn-should bind any T4 or T3 present and thereby diminish resin to 1 liter of their availability for cross-reaction with the DIT antitil <t1% of DIT body. When DIT-free, thyroxine-poor, normal human a trace~r oft [] -serum was added to the incubation mixture (400 pl/ml) the ie Hd Cl-and cross-reactivity of T4 was appreciably diminished (Fig. 3) .
i, and Ca++ The Amounts of T4 up to 600 ng/tube (150 ,ig/100 ml of serum protein electro-using a 400-,ul serum sample) have no effect on this assay, he resin-T3 uptake whereas, without TBG, amounts above 10 ng/tube or 2.5 was decreased by Ag/100 ml of serum would cross-react. When varying amounts of DIT were added to different aliquots of MIT-free serum and DIT content of these sera was measured in the polyethylene glycol radioimmunoassay system, the amount of DIT measured was a direct linear function of the amount of DIT added. When a single aliquot of DIT-free serum was enriched with D-IT to 50 ng/ml and the DIT content of 25, 50, 100, 200, and 400 Al of this serum was measured, the recovery curve obtained was virtually identical. When, however, fresh serum samples from healthy hospital personnel were similarly studied the results varied. Some but not all sera gave improper recovery curves in which the amount of DIT measured was not a direct function of the volume of serum sample assayed. This indicated either DIT-binders or other, as yet unknown, factors nonspecifically interfered with the assay. Therefore, attention was turned to an iodoaminoacid extraction of the serum samples.. Serum extraction. Iodotyrosines and iodothyronines were extracted from 2 ml of serum with 3.0 ml of n-butanol: ethanol 1:1 in 17 X 100-mm plastic test tubes (Falcon Plastics, Division of Becton Dickinson Laboratories, Inc., Oxnard, Calif.). After thorough vortexing, the tubes were placed on a rotary shaker for 2 h, then vortexed again and centrifuged at 2000 g at 4VC for 5 min. Extraction recovery was determined by the addition of [1"I]DIT (3,000-4,000 cpm) to a separate aliquot of the sample. After incubation for 30-60 min at room temperature this aliquot was extracted in the same way, and the percent extraction was calculated as the percent radioactivity present in the supernate. The percent recoveries from 78 serum samples ranged from 79-100% with a mean of 86%. There was no significant difference (P > 0.2) between the mean recoveries from sera of normal subjects, and patients with hyperthyroidism, hypothyroidism, or Hashimoto's thyroiditis. This extraction recovers an average of 82% of serum T4.
Radioimmunoassay of serum extracts. When butanol:
ethanol extraction of serum samples preceded DIT measurements the assay recoveries of DIT from DIT-enriched, DIT-free serum ranged from 86-108% and averaged 98%o. Furthermore, the nonspecific effects of serum, present in some of the unextracted serum samples, were not encountered. The DIT in these extracts was entirely ultrafilterable through a Millipore Pellicon filter with a molecular weight cutoff of 1,000 and exclusion limits of 750-1,250 mol wt.
The possibility of iodothyronine conversion to iodotyrosines during the extraction step was studied in two ways. When random normal serum samples that gave proper linear recovery curves in the unextracted assay were measured in that system the mean DIT concentration was not significantly different from that measured after extraction. When T4 was added to a pool of normal serum with a T4 concentration of 8 ,ug/100 ml the mean of triplicate DIT determinations was the same over the range of 0-15 Ag/ 100 ml of T4 added or a total T4 concentration of 8-23 ,ug/ 100 ml.
The assay finally employed used 1 ml of a butanol: ethanol extract of serum and DIT standards dissolved in butanol: ethanol. Both standards and unknowns were run in triplicate, and all samples from one subject were run in the same assay. Both were dried down in 10 X 75-mm glass culture tubes in a 40°C water bath under compressed air. 100 ul of DIT antiserum diluted 1: 150 in PBS were added bringing it to a total volume of 1 ml. The tubes were thoroughly vortexed, then incubated at 40C for 2 h (the time needed for the DIT-antiDIT reaction to reach equilibrium). After the addition of polyethylene glycol, the tubes were centrifuged at 2000 g for 30 min at 40C. The supernate was decanted, and the radioactivity in the precipitate was counted in a Nuclear Chicago 1185 automatic well type gamma counter (Nuclear Chicago Corp., Des Plaines, Ill.).
The standard curves are linear on a logit-log plot, and the assay results could be analysed by computer using the program of Rodbard, Bridson, and Rayford (16) . The counts were simultaneously printed and punched out on paper by a Teletype model 8470 (Teletype Corporation, Skokie, Ill.) connected directly to the gamma counter. By using the paper tape, the standard curve was drawn, quality control data were calculated, and unknown values were interpolated (16) with an EMR 6130 computer (EMR-Instruments, Sarasota, Fla.) and a Calcomp 565 plotter (California Computer Products, Inc., Anaheim, Calif.). All standards and unknowns were run in triplicate. During patient perturbations all samples were run in the same assay.
Assay precision, including the extraction step, was such that the intraassay coefficient of variation among 12 replicates was 8.7 at 1,000 pg/tube and 3.6 at 4,000 pg/tube, and the interassay coefficient of variation among 16 replicates was 15.7 at 1,000 pg/tube. Assay sensitivity was calculated from the mean±2 SD of the counts bound in 10 replicates of the "zero" tubes. Sensitivity has averaged 140 pg/tube or 35 ng/100 ml of serum and has been as low as 40 pg/tube or 10 ng/100 ml in the best runs.
RESULTS
The DIT concentrations found in human serum are shown in Fig. 4 . 35 apparently healthy young adult controls had random DIT levels ranging from 63-432 ng/100 ml with a mean of 156 ng/100 ml. The random levels in 11 untreated hyperthyroid patients ranged Hour of the Day FIGURE 5 Hourly DIT levels in control s arrows indicate meals. from 44-580 ng/100 ml. Some were higher were lower than the control values, but 158 ng/100 ml was not significantly dii controls. Among 15 patients with untrea hypothyroidism the random values range detectable (< 24 ng/100 ml) to 324 ng/ a mean of 84 ng/100 ml which was signifi (P < 0.01) than the controls. Five patiei opsy-proven, untreated, euthyroid Hashimc itis had random DIT levels of 63-184 ng/ a mean of 114 ng/100 ml. This was not different from either control levels or thyroid levels (P > 0.05). When DIT w hourly for 24 h in five healthy volunteer no detectable diurnal pattern (Fig. 5) . This true when each individual's DIT levels we as a percent deviation from that individual' The wide standard error of the mean is individual variation in DIT levels (78-316
When paired serum samples were ol When 10 mg of DIT in aqueous solution were administered orally to three fasting healthy volunteers serum DIT rose promptly from base line levels of 200-420 ---0--------' ng/100 ml (mean 320) to peak levels of 11,200-13,100 ng/100 ml (mean 12,200) 60 min later. The three ubjects. The curves were very similar and the mean values (±SE) are shown in Fig. 6 . After 60 min the DIT levels fell exponentially with a half-time of 102 min. Since the r, and others DIT levels in the athyrotic patients were obtained the mean of during fasting and hence many DIT half-lives after fferent from the last meal, ingestion of iodoaminoacids seems unted, primary likely to account for the DIT in their serum. The d from un-relative unimportance of food intake as a direct source 100 ml with of circulating DIT is also shown by the absence of icantly lower any significant postprandial rise in DIT levels during nts with bi-the diurnal pattern study (Fig. 5 ).
to's thyroid- phasic response with a small rise in DIT levels after TSH which became apparent at 8 h. One subject showed a biphasic response with a fall in DIT at 8 h followed by a rise at 24 h. Fig. 7 shows the mean of the four similar responses (middle) and the one biphasic response (top) as well as mean To responses (bottom), which were similar in all five subjects. The 2-h levels, which are not shown, were not different from the basal levels. Because the mean basal levels vary so widely (63-216 ng/100 ml) the before-TSH and after-TSH levels for the group of four subjects were not significantly (P > 0.05) different. However, when the mean of the three before-TSH DIT levels for each 'subject were compared with the mean of the 8-, 24-, and 48-h DIT levels after TSH for that same individual the differences were all significant (P < 0.05).
Ts suppression with 100 Ag P. 0. daily was begun on the 5th post TSH day and continued for 12 days.
Though serum DIT had returned to basal levels by day 5 it did not fall below basal levels during Ts administration despite a fall in mean T4 from 8.5 to 5.0 Ag/100 ml. FIGURE 7 Serum DIT and T4 levels after TSH injection.
plasma have raised question regarding the acceptability of the reported results (4, 5, 7) . The radioimmunoassay of DIT provides far greater sensitivity and specificity than existing methods for measuring DIT in biologic fluids and its readily applicable to large numbers of samples. Assay specificity has been made even greater than the inherent DIT antibody specificity by using a unique multiple ligand-binding system in which TBG was used as a second binding protein to combine with free To and T3 in the-incubation mixture thereby reducing their cross-reaction with the DIT antibody. This increase in specificity made it possible to measure low concentrations of DIT in the presence of the high concentrations of T4 found in serum. None of the antisera produced possess less than 0.5% (1-200) To crossreactivity. Since the terminal iodinated phenolic ring of both To and DIT possess the same molecular configuration, it is unlikely that antibody specificity alone would allow the measurement of DIT in the presence of up to 1,000-fold greater T4 concentrations. This multiple ligand-binding principle would seem to have general application for improving radioimmunoassay specificity for closely related molecules.
The presence of measurable DIT levels in all but one of the 78 sera tested is convincing evidence that this iodotyrosine is ordinarily present in the human circulation. The fact that the concentration was decreased in thyroid failure and athreosis, increased after TSH stimulation in normals, and higher in thyroid vein blood than in arterial blood provides conclusive evidence for thyroidal release of iodotyrosines as the source of some of the iodotyrosine in the circulation.
The mean DIT concentration of 156 ng/100 ml in the control subjects represents 90 ng/100 ml (0.09 Mg/ 100 ml) of DIT iodine. This is in reasonable agreement with the report of Weinert, Masui, Radichevich, and Werner (5) who employed a complex and arduous system of extraction, filtration, reduction, and chromatography to measure DIT iodine in two normal human sera and found mean concentrations of 0.30 and 0.39 Ig/ml, respectively. It is close to the mean of 0.16 lg/ 100 ml of DIT iodine in 10 normal subjects reported by Arosenius (6) using ion exchange resin extraction of serum iodoaminoacids followed by acid elution from the resin and separation of the iodoaminoacids by highvoltage paper electrophoresis.
Since only 60% of serum DIT is TCA-precipitable, DIT iodine would account for approximately 0.05 Iug/ 100 ml of the protein-bound iodine, indicating that DIT iodine contributes little to the circulating nonhormonal protein-bound iodine. The possibility that some of the extractable DIT measured in serum might be bound in very small polypeptide molecules (mol wt < 750) instead of "free," is a subject for further study.
The presence of measurable levels of DIT in four athyrotic subjects provides evidence for extrathyroidal sources of circulating DIT. Ingestion of iodotyrosines (or iodoproteins subsequently digested to iodotyrosines) is a possible nonthyroidal source of circulating DIT as shown by the striking rise in serum DIT after DIT administration. The rapid removal of this DIT from the circulation and the absence of measurable postprandial DIT elevations in the 24-h study suggest that this is, at best, a minor source of DIT in serum.
DIT rose slightly after TSH stimulation but not to the degree that T4 rose, and 12 days of T3 suppression did not significantly lower DIT levels despite a fall in T4. This raises the question of the role of TSH in controlling thyroidal DIT release. TSH stimulates thyroglobulin hydrolysis and the release of free iodoaminoacids within the thyroid (1) . TSH also increases the activity of thyroidal iodotyrosine deiodinase (1) . These two effects of TSH would exert opposite influences on thyroidal DIT release. If the former predominated DIT release would increase, but if the latter were predominant DIT release would diminish. Furthermore, the level of DIT in the peripheral blood is the result of both DIT release into and DIT removal from the circulation. There is evidence that the thyroid takes up DIT from the circulation (18) , and it is possible that this thyroidal uptake of iodotyrosines may be altered by TSH thereby introducing still another variable in the TSH effect on circulating DIT levels. The variable pattern of DIT response to TSH administration seen in this study suggests that the interplay of these factors may be different from one subject to another. The small change in DIT concentration after TSH administration and the absence of a measurable change after TSH suppression with T3 are in striking contrast to the changes in T4. This implies that either opposing TSH responsive processes largely counterbalance each other or that TSH is not as important a factor in the control of circulating iodotyrosine concentrations as it is for the iodothyronines.
The finding of iodotyrosine in the serum of athyrotic and hypothyroid humans confirms the findings of Row, Webster, Ezrin, Johnston, and Volpe (19) and provides a possible explanation for the fact that attempts to measure iodotyrosines in serum by methods that detect chemical iodine have generally given higher estimates of serum concentrations than methods which rely on in vivo labelling of iodotyrosines after the administration of radioactive iodine (4).
